RHOEN-KLINIKUM AG/ DE0007042301 /
| 12/30/2020 12:00:00 AM | Chg. - | Volume | Bid10:37:07 AM | Ask1:17:50 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 16.24EUR | - | 1 Turnover: - |
-Bid Size: - | -Ask Size: - | 843.42 mill.EUR | - | 21.72 |
Assets
|
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 858.2000 | 865.6000 | 852.6000 | 822.4950 | 792.1080 | ||||||
| Intangible Assets | 178.1000 | 181.6000 | 181.6000 | 13.9000 | 10.5000 | ||||||
| Long-Term Investments | 3.3000 | 14.6000 | 19.2000 | .8290 | .5330 | ||||||
| Fixed Assets | 1,068.9000 | 1,063.2000 | 1,054.5000 | 1,016.3360 | 981.3130 | ||||||
| Inventories | 28.4000 | 35.2000 | 33.1000 | 33.3180 | 34.2140 | ||||||
| Accounts Receivable | 226.6000 | 193.9000 | 212.9000 | 228.6020 | 229.5280 | ||||||
| Cash and Cash Equivalents | 127.7000 | 91 | 126.3000 | 77.3340 | 206.0420 | ||||||
| Current Assets | 563 | 566.4000 | 611.1000 | 688.6080 | 789.2110 | ||||||
| Total Assets | 1,631.9000 | 1,629.7000 | 1,665.6000 | 1,704.9440 | 1,770.5240 | ||||||
Liabilities
|
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 84.5000 | 80.7000 | 72.5000 | 69.9860 | 66.8350 | ||||||
| Long-term debt | 182.1000 | 165 | 166.1000 | 141.6750 | 141.7760 | ||||||
| Liabilities to Banks | 218.1000 | 180.8000 | 179.2000 | - | - | ||||||
| Provisions | 14 | 32.4000 | 32.2000 | 34.4830 | 40.7000 | ||||||
| Liabilities | 470.4000 | 464.4000 | 440.8000 | 453.5110 | 490.2980 | ||||||
| Share Capital | 167.4060 | 167.4060 | 167.4060 | - | - | ||||||
| Total Equity | 1,161.5000 | 1,165.3000 | 1,198.3000 | 1,223.8020 | 1,252.0400 | ||||||
| Minority Interests | - | - | - | 27.6310 | 28.1860 | ||||||
| Total liabilities equity | 1,631.9000 | 1,629.7000 | 1,665.6000 | 1,704.9440 | 1,770.5240 | ||||||
Income Statement
|
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 1,303.9000 | 1,360.2000 | 1,402 | 1,446.0860 | 1,473.9790 | ||||||
| Depreciation (total) | 68.7000 | 69.4000 | 70.6000 | 69.5330 | 64.4850 | ||||||
| Operating Result | 56.8000 | 10.6000 | 30.5000 | 36.1120 | 40.3990 | ||||||
| Interest Income | -2.8000 | -6.6000 | -2.7000 | -2.7800 | 6.8310 | ||||||
| Income Before Taxes | 54.2000 | 3.9000 | 27.4000 | 33.6290 | 47.7290 | ||||||
| Income Taxes | 9.8000 | 1.5000 | 2.9000 | 6.6890 | 7.5620 | ||||||
| Minority Interests Profit | -1.2000 | -1 | -1.9000 | 1.7960 | 1.4550 | ||||||
| Net Income | 43.3000 | 1.5000 | 28.3000 | 25.1440 | 38.7120 | ||||||
Per Share
Cash Flow
|
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 47.3000 | 113.3000 | 97.5000 | 60.3000 | 109 | ||||||
| Cash Flow from Investing Activities | -86.7000 | -135.2000 | -58.3000 | -105.2000 | 40.9000 | ||||||
| Cash Flow from Financing | 35.1000 | -15.1000 | -3.9000 | -4.1000 | -21.2000 | ||||||
| Decrease / Increase in Cash | -4.3000 | -37 | 35.3000 | - | - | ||||||
| Employees | 17,687 | 18,449 | 18,227 | 13,840 | 14,021 | ||||||
